Article info
PDFResearch paper
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies
- Correspondence to Professor D Aarsland, Department of Old Age Psychiatry, Psychiatric Clinic, Stavanger University Hospital, PO Box 8100, N-4068 Stavanger, Norway; daarsland{at}gmail.com
Citation
CSF amyloid β38 as a novel diagnostic marker for dementia with Lewy bodies
Publication history
- Received November 5, 2009
- Revised February 15, 2010
- Accepted February 23, 2010
- First published November 3, 2010.
Online issue publication
January 05, 2011
Article Versions
- Previous version (3 November 2010).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.